Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.
about
Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase IIPhase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer.Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid.[Advances on treatment of small cell lung cancer with amrubicin].Phase I/II study of amrubicin in combination with S-1 as second-line chemotherapy for non-small-cell lung cancer without EGFR mutation.
P2860
Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Amrubicin, a novel 9-aminoanth ...... er cells in vitro and in vivo.
@en
type
label
Amrubicin, a novel 9-aminoanth ...... er cells in vitro and in vivo.
@en
prefLabel
Amrubicin, a novel 9-aminoanth ...... er cells in vitro and in vivo.
@en
P2093
P2860
P1433
P1476
Amrubicin, a novel 9-aminoanth ...... er cells in vitro and in vivo.
@en
P2093
Mitsuhara Hanada
Takashi Yamaoka
Toshihiro Noguchi
P2860
P304
P356
10.1111/J.1349-7006.2007.00404.X
P577
2007-03-01T00:00:00Z